Halaman 2 - Trombositopenia Dokter Terbaik - TOP-41 dokter

Dr. Francesc Bosch is an expert in Chronic Lymphocytic Leukemia (CLL) and lymphomas. He leads research in the molecular causes and new treatments for CLL and other lymphoproliferative disorders.

He has published over 100 articles in leading journals, including The New England Journal of Medicine and Nature Medicine. Dr. Bosch oversees more than 80 clinical studies, from phase 1 to phase 3, and plays a key role in developing new drugs.

He is the Head of Hematology at Vall d’Hebron University Hospital and IOB Institute of Oncology. He also serves as president of GELLC and is a professor of hematology. His work has improved diagnosis and treatment for blood diseases.

Dr. Blanca Lopez Ibor is an experienced specialist in children’s hematology and oncology from Spain. She is a lecturer at the Universidad Complutense de Madrid and Universidad CEU San Pablo, and is a consultant for the WHO and UNESCO. Dr Lopez Ibor has over 30 years of experience diagnosing and treating hematological and cancer disorders in children. She is also the head of two foundations that help children with severe health problems.

Dr. Prakash Pandit is an MD in Radiation Oncology and works as a Consultant. He has expertise in advanced cancer treatments. He specializes in Tomotherapy-H, Linear Accelerator, and Brachytherapy. He provides modern care for various types of cancer.

Dr. Pandit is known for his work in radiation oncology. He uses the latest technology to help patients. He has treated many complex cases. He always maintains high standards of safety and accuracy in his treatments.

Dr. López-Ibor is a specialist in Pediatric Hematology and Oncology. She earned her medical degree from the Complutense University of Madrid and her doctorate from the University of Barcelona. She is also accredited by the University of Maryland. Dr. López-Ibor treats bone and brain tumors, leukemia, and blood disorders.

She has over 20 years of experience. Dr. López-Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital. She has written many scientific articles, both nationally and internationally, and has made important contributions to her field.

Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

His medical interests include:

Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)

Acute Leukemia

Chronic Leukemia Treatments

Hodgkin Lymphoma

Non-Hodgkin Lymphoma Treatments

Multiple Myeloma Treatments, MDS

Aplastic Anemia

ITP

TTP Treatments

Hypercoagulability

Hereditary Thrombophilia Treatments

Therapeutic Apheresis

Photopheresis

Geriatric Hematology Diseases.

Prof. Dr. Ceyhun Bozkurt is a respected Pediatric Hematologist-Oncologist. He is known for his work in childhood blood disorders and cancers. He graduated from Cerrahpaşa Faculty of Medicine. He holds specializations in both Pediatrics and Pediatric Oncology. Since 2019, he has been Professor and Clinical Director at Bahçelievler Medical Park Hospital. He also serves as Vice Director of the Stem Cell Transplant Unit.

Dr. Bozkurt has published over 40 peer-reviewed articles. He is recognized for his work in leukemia, bone marrow transplantation, and stem cell therapy. He is a member of organizations such as SIOP and EBMT. His memberships show his dedication to high standards in clinical care and research.

Prof. Dr. Şebnem İzmir Güner was born in 1970 in Istanbul and took her first steps in her medical career at Istanbul University Faculty of Medicine. Successfully completing her undergraduate and medical education here between 1987-1993, Güner received her internal medicine specialty training at Istanbul University Cerrahpaşa Faculty of Medicine from 1995 to 2000. Deepening her interest in hematology, Prof. Dr. Güner completed her hematology subspecialty training at Cerrahpaşa Faculty of Medicine again between 2003-2006, solidifying her expertise in this field.
Prof. Dr. Güner’s professional journey began as an internal medicine specialist at Istanbul Education and Research Hospital from 2000 to 2003. She established the Hematology Clinic at the same hospital from 2006 to 2010 and served as the responsible physician. Here, she developed innovative approaches in the treatment of patients and made significant contributions to the field of hematology. From 2010 to 2016, she established the Hematology Clinic, Therapeutic Apheresis, and Adult Bone Marrow Transplantation Center at Medicalpark Bahçelievler Hospital and served as the responsible physician. During this period, she conducted studies that set national and international standards in the field of hematology.
Between 2016-2018, Prof. Dr. Güner took on similar roles at Şişli Kolon International Hospital, where she was also the founder and responsible physician of the Hematology Clinic, Therapeutic Apheresis, and Adult Bone Marrow Transplantation Center. Güner, who became an associate professor in 2017, obtained her professorship title in 2023. Between 2019-2024, she worked at Memorial Şişli Hospital in the Hematology Clinic, Therapeutic Apheresis, and Adult Bone Marrow Transplantation Center.
Prof. Dr. Şebnem İzmir Güner is recognized for her scientific contributions, with over 19 articles published in international peer-reviewed journals. Additionally, she has over 18 articles published in national peer-reviewed journals and 51 presentations at national scientific meetings that have been published in proceedings books. She has also made a name for herself in the academic world with over 18 presentations at meetings and published in proceedings books. Güner, who has held positions on the boards of domestic hematology associations and has active memberships, has crowned her success with more than three awards given at universities and conferences.
Prof. Dr. Şebnem İzmir Güner, who speaks English and German, is also recognized as an educator. In this capacity, she has contributed to the training of young doctors in the field of hematology, providing education to research assistant doctors and students.
Prof. Dr. Şebnem İzmir Güner has established a respected place in the field of hematology with her achievements and scientific contributions throughout her professional life, continuing her career as a physician who inspires her patients and colleagues.

MEDICAL INTERESTS

• Leukemia
• Lymphoma
• Multiple myeloma
• Bone marrow transplantation
• Anemia
• Bleeding and coagulation disorders
• Hemophilia

Dr. Leylagül Kaynar is a hematologist with broad experience in clinical hematology, bone marrow transplantation, and apheresis. She completed her medical degree and specialist training at Erciyes University in Turkey. There, she worked as Assistant Professor, Associate Professor, Director of the Apheresis Unit, and Head of the Hematology Department.

Dr. Kaynar gained international research experience as a Visiting Research Scholar at Duke University in the USA. She also led the Hematology and Bone Marrow Transplantation Department at the Bahrain Oncology Center, where she improved hematology care in the region. Dr. Kaynar is now Professor and Head of Hematology and Bone Marrow Transplantation at Medipol Mega University Hospital in Turkey. She is known for her leadership and contributions to hematology and transplantation services.

Dr. Hilmi Apak is a respected pediatric hematology-oncology specialist with more than 21 years of experience. He is trained in pediatric oncology. Dr. Apak has led advanced treatments, including bone marrow transplantation, leukemia chemotherapy, and CAR T-cell therapy.

He has published 75 international medical articles, showing his strong contribution to pediatric oncology research. Dr. Apak has worked as assistant editor for the Turkish Pediatrics Archives Periodical. He has also held important academic and leadership positions, such as Head of Pediatric Hematology-Oncology at Istanbul University-Cerrahpaşa.

Education

• Undergraduate: Istanbul Faculty of Medicine, Istanbul University, 2007
• MSc (Internal Medicine Department): Marmara University Faculty of Medicine, 2012
• PhD (Hematology Clinic): Istanbul Training and Research Hospital, 2018
• Associate Professor (Hematology Clinic): Prof.Dr.Cemil Tascioglu Training and Research Hospital, 2019

Prof. Dr. Rafet Eren graduated from Istanbul Faculty of Medicine in 2007. He completed his Internal Medicine specialty training at Marmara University Faculty of Medicine in 2012. In 2018, he became a Hematology subspecialist at Istanbul Training and Research Hospital. In 2019, he was awarded the title of Associate Professor in the field of Hematology. Afterwards, he worked as a faculty member at Başakşehir Çam and Sakura City Hospital, Bozyaka Training and Research Hospital and Istinye University (Istinye University Bahçeşehir and Liv Hospital Vadistanbul) and is currently working at Biruni University Hospital. Dr. Rafet Eren is a member of Turkish Society of Hematology, Hematology Specialty Society and European Society of Hematology and speaks English fluently. He has around 50 publications in national and international refereed journals.

Scientific Memberships

• Turkish Hematology Association
• Hematology Specialty Society
• Turkish Internal Medicine Specialty Society
• European Society of Hematology
•  

Awards 

• Young Researcher Award (42nd National Hematology Congress), 2016
• Special Jury Paper Award (3rd Hematologic Oncology Congress), 2015
• Paper 3rd Prize (2nd Hematologic Oncology and Bone Marrow Transplantation Symposium), 2016

Pendidikan

• Fakultas Kedokteran Ege 1978
• Spesialisasi di bidang Pediatri 1982
• Subspesialisasi Onkologi Pediatrik 2002 (Fakultas Kedokteran EU)
• Hematologi dan Onkologi Pediatrik 2012 (Fakultas Kedokteran EU)
• Wakil Kepala Klinik 1988 Tepecik EAH
• Kepala Klinik 1993 Tepecik EAH
• Asosiasi Profesor 1995
• Profesor 2002
• Anggota Fakultas Fakultas Kedokteran Ege U. 1998 – 2022
• Departemen Kedokteran Anak Fakultas Kedokteran EU 2009-2018
• Anggota Dewan Perencanaan dan Koordinasi Pendidikan Tepecik (1993-1998)
• Ketua Komite Etik Rumah Sakit SSI Tepecik (1996-1998)
• Masyarakat Hematologi Anak Turki "Wakil Ketua Kelompok Kerja Transplantasi Sumsum Tulang" (2002-2006)
• Masyarakat Hematologi Anak Turki "Kelompok Kerja Transplantasi Sumsum Tulang" (2006-2008)
• Masyarakat Hematologi Anak Turki - Bertanggung jawab atas Sistem Registri Data "Online" Transplantasi Sumsum Tulang 2007-sekarang.
• Ketua Komisi Kedokteran Regeneratif dan Sel Punca Universitas Ege, 2011-2021

Keanggotaan Institusi

• Asosiasi Medis Turki Cabang İzmir dan Kocaeli
• Asosiasi Pediatri Nasional Turki - İzmir
• Grup Eropa untuk Transplantasi Sumsum Tulang (EBMT); Unit Transplantasi Sumsum Tulang Pediatrik Universitas Ege terakreditasi oleh Grup Eropa untuk Transplantasi Sumsum Tulang (EBMT) pada Juni 2007.
• Masyarakat Hematologi Anak Turki - Anggota Dewan selama dua periode (2005-2009)
• Masyarakat Hematologi Turki - Anggota Dewan selama dua periode (2001/2005)
• Asosiasi Onkologi Pediatrik Turki
• Yayasan Transplantasi Sumsum Tulang (KITVAK) Anggota Dewan Pengawas

Unit yang Didirikannya                        

1- Klinik Onkologi Pediatrik Rumah Sakit SSI Tepecik (1990) 
2- Unit Transplantasi Sumsum Tulang Pediatrik Rumah Sakit SSI Tepecik (1992) 
3- Unit Transplantasi Sumsum Tulang Pediatrik Fakultas Kedokteran EU (1998) 
4- PENDIRI JURNAL PENELITIAN PEDIATRIK, 2014; aplikasi SCI dilakukan pada 2022. 

Unit Transplantasi yang Dia Berkontribusi dalam Pendirian                        

1. Unit Transplantasi Sumsum Tulang Pediatrik İzmir BUÇH EAH (2019) 
2. Unit Transplantasi Sumsum Tulang Pediatrik Ümraniye EAH (2020) 
3. Unit Transplantasi Sumsum Tulang Pediatrik Kanuni Sultan Süleyman EAH (2020) (Dipindahkan ke Çam Sakura EAH)

Penghargaan

• Parameter trombotik pada pasien transplantasi sel punca sumsum tulang, Kongres Hematologi Pediatrik, Trabzon 2003
• Antigen CD133 dalam Sel Punca: Kongres Hematologi Pediatrik 2005. Penghargaan penelitian
• Peran reseptor Toll seperti pada pasien neutropenik febril, penghargaan poster terbaik. Kongres Hematologi Turki 2008, Çeşme-İzmir
• Kegiatan transplantasi sel punca pediatrik nasional- Penghargaan presentasi lisan kedua, Kongres Transplantasi Sel Punca Masyarakat Hematologi Turki, 2022, Antalya

Publikasi

Kansoy S. "Transplantasi Sumsum Tulang dan Sel Punca Kesehatan Anak dan Penyakit, edisi pertama, Percetakan Fakultas Kedokteran EU, 1999, İzmir

Kansoy S. Transplantasi sumsum tulang pada Thalassemia Major III. Buku Hari Thalassemia Aegea, 2000, Izmir

Kansoy S. Standar Pusat KIT Pediatrik di Turki. Leukemia Akut Anak, Antalya 2000: 73-5

Kansoy S. Efek Samping Jangka Panjang pada Anak. Edisi khusus Jurnal Transplantasi Sumsum Tulang Klinik Turki. 2003

Kansoy S. Aplikasi Sel Punca dalam Transplantasi Sumsum Tulang dan Sel Punca. Buku Kursus Keperawatan Onkologi Pediatrik, İzmir, 2005

Kansoy S. Darah Tali Pusat sebagai Sumber Sel Punca. Edisi Khusus Sel Punca. Klinik Turki, 2008

Kansoy S. Transplantasi Sel Punca pada Limfoma. Buku Pediatri Umum, Ed. Prof.Dr.Enver Hasanoglu, 2009

Kansoy S, Aksoylar S. Transplantasi Sumsum Tulang pada Anak. Pediatri, 2014 dan 2017

Kansoy S. Rhabdomyosarcoma. Pediatri, 2014 dan 2017

Kansoy S. Pendekatan kepada Anak dengan Kanker Berdasarkan Temuan Klinis. Pediatri, 2014 dan 2017 

11. Çetingül N, S.Kansoy, M.Kantar. Penyakit Onkologis. Pediatri (Ed. A. Cura), 641-672, Percetakan Universitas Ege, İzmir, 1999.  (1.05 poin)

Kansoy S, M.Kantar. Pemeriksaan Kepala, Wajah, dan Mata. Pemeriksaan Fisik Prostetik Pediatrik dan Informasi Gejala (Ed. A.Cura)

Kantar M. Masalah Darurat Metabolik dalam Onkologi. Darurat Onkologi dan Perawatan Dukungan pada Anak (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, İzmir, 2003. 

Transplantasi Darah Tali Pusat di Turki. HEMATOLOGIST, 2016

Kansoy S. Tumor Sistem Saraf Pusat pada Anak Pediatri, 2014 dan 2017

Leukemia mieloblastik akut pada anak dan pengobatannya. Buku Ajar Onkologi Pediatrik, Turki Poplack, 2020

Kegiatan transplantasi sel punca pediatrik nasional, 2020

Indikasi transplantasi sel punca anak, Klinik Turki - Buku Internasional 2020

Selain studi dan makalah di jurnal internasional yang diterbitkan dalam jumlah besar, dia terlibat dalam studi multinasional internasional di beberapa jurnal dengan nilai dampak tinggi.

Dr. Francesc Cobo Valien graduated from the Faculty of Medicine of the University of Barcelona in 1990.

He received his specialization in oncohematology at the Hospital Clínic de Barcelona in 1995. He combined medical practice and research activities in the period 1996-2002.

He received his Doctor of Medicine degree from the University of Barcelona in 2002.

Dr. Kobo continues his research and has been awarded grants:

•Interdepartmental Commission for Innovation of the Generalitat de Catalunya

•Scholarship Fund Universitaria Agustí Pedro i Pons

•Farreras Valentí & Schering Plough School of Hematology Scholarship

•Award for the best report at the Council of the Spanish Hematology Association

•Grant from the Catalan Society of Hematology

Specialization:

•Lymphoma

•Acute leukemia

•Chronic leukemia

•Autoimmune pancytopenia

Eduardo Fernandez, MD

Medical Doctor & Stem Cell Expert

Dr. Eduardo Fernandez is a distinguished medical professional specializing in stem cell therapies and regenerative medicine. He is a certified member of the Mexican College of Stem Cells and Regenerative Medicine, as well as the Mexican Council of Stem Cells for Therapeutic and Research Purposes. Dr. Fernandez’s certifications are the result of a rigorous 8-hour examination process, reserved for a select group of doctors who possess advanced knowledge and experience in these cutting-edge treatments. With only 50 certified doctors in Mexico, Dr. Fernandez’s expertise is highly sought after and respected.

In addition to his national recognition, Dr. Fernandez is awaiting international certification from the renowned International Society for Stem Cell Research (ISSCR). Membership in this prestigious organization signifies Dr. Fernandez’s extensive experience and expertise in stem cell treatments. The ISSCR includes prominent scientists from renowned universities such as Harvard, Yale, Stanford, and other esteemed institutions worldwide. Being a part of this elite society represents the pinnacle of honor and prestige in the field of stem cell therapies.

Furthermore, Dr. Fernandez is also seeking membership and international certification from the International Society for Extracellular Vesicles (ISEV), the largest community of extracellular vesicle researchers globally. With only two thousand members worldwide, ISEV’s select nature underscores Dr. Fernandez’s exceptional dedication to advancing scientific knowledge in the study of exosomes and cellular messengers. By pursuing membership in ISEV, Dr. Fernandez continues to demonstrate his commitment to staying at the forefront of research and innovation in the field of regenerative medicine.

Medical Experience:

- 2024 - Present: Memorial Şişli Hospital  

 Specialist in Internal Medicine and Hematology / Istanbul

- 2017 - 2024: Istanbul Florence Nightingale Hospital  

 Specialist in Internal Medicine and Hematology / Istanbul

- 2015 - 2017: Eskişehir Yunus Emre State Hospital  

 Hematology Specialist - Compulsory Service / Eskişehir

Medical Education:

- 2020 - 2024: Istanbul Florence Nightingale Hospital  

 Demiroğlu Bilim University, Faculty of Medicine / Istanbul, Turkey

- 2017 - 2020: Istanbul Florence Nightingale Hospital  

 Demiroğlu Bilim University, Faculty of Medicine / Istanbul, Turkey

- 2011 - 2015: Eskişehir Osmangazi University, Faculty of Medicine, Department of Hematology / Eskişehir, Turkey

- 2009 - 2011: Harvard University, Faculty of Medicine / Boston, USA

- 2000 - 2008: Ankara University, Faculty of Medicine / Ankara, Turkey

- 1994 - 2000: Ankara University, Faculty of Medicine / Ankara, Turkey

Attended Professional Trainings, Courses, and Conferences:

- European Society for Blood and Marrow Transplantation, 3rd EBMT International Transplant Course, Barcelona, Course, 07.09.2018-09.09.2018 (International)

- Turkish Academy of Blood Science, Lymphoma Masterclass, Istanbul, Course, 01.09.2016-01.03.2017 (National)

- Advanced Life Support Course, Istanbul

Membership in Professional Associations:

- European Society for Blood and Marrow Transplantation

- Turkish Academy of Blood Science

- Advanced Life Support Course

Experience

• 1990 - 1994 – General Practitioner
• 1994 - 2001 – Research Assistant, Erciyes University, Faculty of Medicine
• 2001 - 2006 – Assistant Professor, Internal Medicine/Hematology, Erciyes University, Faculty of Medicine
• 2006 - 2011 – Associate Professor, Internal Medicine/Hematology, Erciyes University, Faculty of Medicine
• 2011 - 2019 – Professor, Internal Medicine/Hematology, Erciyes University, Faculty of Medicine

Professional Memberships

• Turkish Society of Hematology
• European Group for Blood and Marrow Transplantation (EBMT)
• Hematologic Oncology Association
• Antalya Medical Chamber

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Dr. Itir Sirinoglu Temiz is a Professor of Hematology. She specializes in lymphoma, acute and chronic leukemias, multiple myeloma, thrombocytopenias, thrombosis, anemia, and bone marrow failure. She graduated with honors from Istanbul University Cerrahpaşa Faculty of Medicine. She completed her hematology training at Dr. Abdurrahman Yurtarslan Oncology Education and Research Hospital.

Dr. Sirinoglu Temiz has held key academic and administrative positions. She served as Head of Internal Medicine at IAU Faculty of Medicine. She was also Education and Administrative Manager at SBÜ Bakırköy Dr. Sadi Konuk EAH Hematology Clinic. She has broad experience in adult hematology, stem cell transplantation, and therapeutic apheresis. She currently practices at Liv Hospital.